09.11.2021 Vita 34 AG  DE000A0BL849

DGAP-Adhoc: Vita 34 AG: Fulfilment of all closing conditions under the Exchange Offer PBKM; Implementation of capital increase; withdrawal of guidance for financial year 2021


 

DGAP-Ad-hoc: Vita 34 AG / Key word(s): Capital Increase/Change in Forecast
Vita 34 AG: Fulfilment of all closing conditions under the Exchange Offer PBKM; Implementation of capital increase; withdrawal of guidance for financial year 2021

09-Nov-2021 / 11:59 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Vita 34 AG: Fulfilment of all closing conditions under the Exchange Offer PBKM; Implementation of capital increase; withdrawal of guidance for financial year 2021

Leipzig, 9 November 2021 - Vita 34 AG ("Vita 34") announces that all closing conditions under the voluntary public exchange offer by Vita 34 addressed to the shareholders of Polski Bank Komórek Macierzystych S.A., Warsaw ("PBKM") have been fulfilled or waived and that the implementation of the capital increase necessary for the completion of the exchange offer was today registered with the commercial register of Vita 34. Based on the resolution of the extraordinary general meeting of Vita 34 held on 13 July 2021, the share capital of Vita 34 was increased from EUR 4,145,959 by EUR 11,890,500 to EUR 16,036,459 by way of issuance of 11,890,500 new no-par-value registered shares. As a result, Vita 34 now holds a total of 9,150,272 PBKM shares (corresponding to approximately 97.98% of the registered capital and outstanding voting rights of PBKM). It is expected that the new shares issued in connection with the capital increase will be delivered to the PBKM shareholders participating in the share exchange until 15 November 2021. Upon delivery of the new shares (or the cash consideration in case of a sale fractional shares) the exchange offer will be completed.

As a result of the completion of the business combination with PBKM, the management board of Vita 34 has today resolved to withdraw the guidance for the financial year 2021. While Vita 34 (on a stand-alone basis) is expected to meet the revenue and adjusted EBITDA targets for the business year 2021, the required harmonization of the accounting standards of PBKM and Vita 34 does currently not permit a new guidance of the combined group for the financial year 2021. A new guidance of the combined group for the financial year 2022 will be provided in the course of the publication of Vita 34's annual report for the financial year 2021.


Contact:
Dr. Wolfgang Knirsch (CEO), Andreas Schafhirt (CFO)

09-Nov-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Vita 34 AG
Deutscher Platz 5a
04103 Leipzig
Germany
Phone: +49(0341)48792-40
Fax: +49(0341)48792-39
E-mail: [email protected]
Internet: www.vita34.de
ISIN: DE000A0BL849
WKN: A0BL84
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1247362

 
End of Announcement DGAP News Service

1247362  09-Nov-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1247362&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 19,19 20,41 19,93 20,07 28,42 68,94 76,80
EBITDA1,2 1,85 4,72 5,43 5,34 0,81 -3,56 4,00
EBITDA-Marge3 9,64 23,13 27,25 26,61 2,85 -5,16
EBIT1,4 0,14 2,63 2,45 2,38 -3,07 -27,28 -4,65
EBIT-Marge5 0,73 12,89 12,29 11,86 -10,80 -39,57 -6,06
Jahresüberschuss1 -0,33 0,83 0,72 1,50 -3,93 -27,38 -5,20
Netto-Marge6 -1,72 4,07 3,61 7,47 -13,83 -39,72 -6,77
Cashflow1,7 1,53 4,60 6,32 3,98 2,73 -4,49 0,00
Ergebnis je Aktie8 -0,09 0,20 0,18 0,37 -0,63 -1,71 -0,29
Dividende8 0,16 0,16 0,00 0,00 0,00 0,00 0,16
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Vita 34
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0BL84 4,660 Halten 82,20
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
17,92 25,60 0,68 -66,57
KBV KCV KUV EV/EBITDA
7,55 - 1,07 20,81
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 28.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
31.05.2024 30.08.2024 22.11.2024 30.04.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-4,37% -4,53% -11,07% -24,35%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Vita 34 AG  ISIN: DE000A0BL849 können Sie bei EQS abrufen


Biotechnologie , A0BL84 , V3V , XETR:V3V